Presence of complete or incomplete septa in human jugular foramens / Presencia de septos completos o incompletos en forámenes yugulares humanos

SUMMARY: The objective of this study was to determine the occurrence of anatomical variants in the exocranial surface of the jugular foramen, specifically, the presence of single or double and complete or incomplete septation. A cross-sectional anatomical study was performed using 96 Brazilian dry human skulls (53 male and 43 female). One examiner determined the number (single or double) and type (i.e. complete or incomplete) of osseous septation at the outer surface of jugular foramens. Data went through statistical analysis on GraphPad Prism 6.01. Our results shown that Male individuals where more likely to present normal jugular foramens (male = 71.69%, female = 34.88%; p = 0.003). However, one incomplete septation occurred more often on the right side of female individuals (1 incomplete septation, male = 16.98%; 1 incomplete septation, female = 34.88%; p = 0.044). Similarly, one complete septation (i.e. the presence of two fully divided jugular compartments) also occurred more often on the right side of female individuals (1 complete septation, male = 9.43%; 1 complete septation, female = 25.58%; p = 0.038). Anatomical variants of the jugular foramen regarding single or double complete or incomplete septations were more likely to be found on the right side of female individuals, whose also presented a higher rate of jugular foramens with any type of septation than regular non-altered jugular foramens.

RESUMEN: El objetivo de la presente investigación fue determinar la presencia de variaciones anatómicas en la superficie exocraneal del foramen yugular, especificamente, la presencia de septos únicos o dobles, completos o incompletos. El estudio fue realizado en 96 cráneos secos (53 masculinos y 43 femeninos) de indivíduos Brasileños. Se determinaron septos óseos completos o incompletos y número de ellos. Los resultados obtenidos fueron tratados estadísticamente con el programa GraphPad Prism 6.01. Los sujetos de sexo masculino fueron más propensos a presentar forámenes yugulares normales (sexo masculino: 71,69%; sexo femenino: 34,88%, p= 0,003). Sin embargo, se observaron septos incompletos con mayor frecuencia en el lado derecho y en el sexo femenino (sexo masculino: 16,98%; sexo femenino: 34,88%, p=0,044). Adicionalmente, una septación completa (presencia de dos compartimientos yugulares, divididos completamente), se presentaron más frecuentemente en el lado derecho de indivíduos femeninos (sexo masculino: 9,43%; sexo femenino: 25,58%, p= 0,038). Las variantes anatómicas del foramen yugular, en relación a septos simples o dobles, completos o incompletos, se encontraron con mayor frecuencia en el lado derecho de las mujeres, las que presentaron un alto rango de forámenes yugulares con algún tipo de septos respecto a los forámenes yugulares regulares no alterados.

Study of major genetic factors involved in pituitary tumorigenesis and their impact on clinical and biological characteristics of sporadic somatotropinomas and non-functioning pituitary adenomas

Genetic and functional aberrations of guanine nucleotide-binding protein, alpha stimulating (GNAS), aryl hydrocarbon receptor interacting protein (AIP), and pituitary tumor transforming gene (PTTG) are among the most prominent events in pituitary tumorigenesis. A cohort of Brazilian patients with somatotropinomas (n=41) and non-functioning pituitary adenomas (NFPA, n=21) from a single tertiary-referral center were evaluated for GNAS and AIP mutations and gene expression of AIP and PTTG. Results were compared to the clinical and biological (Ki67 and p53 expression) characteristics of tumors and their response to therapy, if applicable. Genetic analysis revealed that 27% of somatotropinomas and 4.8% of NFPA harbored GNAS mutations (P=0.05). However, no differences were observed in clinical characteristics, tumor extension, response to somatostatin analog therapy, hormonal/surgical remission rates, Ki67 index, and p53 expression between mutated and non-mutated somatotropinomas patients. PTTG overexpression (RQ mean=10.6, min=4.39, max=11.9) and AIP underexpression (RQ mean=0.56, min=0.46-max=0.92) were found in virtually all cases without a statistically significant relationship with clinical and biological tumor features. No patients exhibited somatic or germline pathogenic AIP mutations. In conclusion, mutations in GNAS and abnormal PTTG and AIP expression had no impact on tumor features and treatment outcomes in this cohort. Our data support some previous studies and point to the need for further investigations, probably involving epigenetic and transcriptome analysis, to improve our understanding of pituitary tumor behavior.

Strontium ranelate as a possible disease-modifying osteoarthritis drug: a systematic review

Considering that osteoarthritis (OA) is the most prevalent joint disease worldwide, multiple pharmacological treatments have been proposed to alter the articular structure with potential benefit in the progression of the disease. The so-called disease-modifying OA drugs have been frequently investigated but conclusive findings are rare. Strontium ranelate (SrRan) is a drug usually prescribed to treat osteoporosis, with proven effects in decreasing the risk of fractures and possible effect in reducing the progression of OA. The objective of this review was to demonstrate the current panorama of knowledge on the use of SrRan in clinical and experimental models, clarifying its mechanisms of action and describing possible anti-nociceptive and anti-inflammatory effects. The systematic review was based on the PRISMA statement and included articles that are indexed in scientific databases. Fifteen studies were included: seven pre-clinical and eight clinical studies. Despite the limited number of studies, the results suggest a positive effect of SrRan in patients with OA, through changes in functional capacity and reduction of progression of morphological parameters and joint degradation, with moderate quality of evidence for those clinical outcomes. Novel studies are necessary to elucidate the molecular targets of SrRan, focusing on anti-inflammatory effects and histological changes promoted by SrRan, which seemed to reduce the progression of OA in the experimental and clinical studies.

Trigeminal neuralgia: literature review

The trigeminal nerve, fifth equal of cranial nerves, a mixed nerve is considered by possessing motor and sensitive components. The sensitive portion takes to the Nervous System Central somesthesics information from the skin and mucous membrane of great area of the face, being responsible also for a neural disease, known as the Trigeminal Neuralgia. The aim of this study was to review the literature on the main characteristics of Trigeminal Neuralgia, the relevant aspects for the diagnosis and treatment options for this pathology. This neuralgia is characterized by hard pains and sudden, similar to electric discharges, with duration between a few seconds to two minutes, in the trigeminal nerve sensorial distribution. The pain is unchained by light touches in specific points in the skin of the face or for movements of the facial muscles, it can be caused by traumatic sequels or physiologic processes degenerative associate the vascular compression. Prevails in the senior population, frequently in the woman. In a unilateral way it attacks more the maxillary and mandibular divisions, rarely happens in a simultaneous way in the three branches of trigeminal nerve three branches.

Morphological characteristics of foramen of Vesaliusand its relationship with clinical implications

The aim of this study was to evaluate the incidence as well morphometry of the foramen of Vesalius in humanskulls and analyzing their clinical importance. Dry human skulls (n = 80) and with gender distinction wereused (40 male and 40 female). The results demonstrates an total incidence of 40%, 13.75% skulls with thebilateral presence of the foramen, 26.25% skulls with the unilateral presence of the foramen, 31.25% skullswith foramen only of the right side, 22.50% skulls with foramen only of the left side, 25% masculine skulls withat least 1 foramen and 52.25% skulls with at least 1 foramen. The morphometry showed an average diameterof 1.457 ± 1.043 mm on the right and 1592 ± 0938 mm to the left. The average distance to the foramenovale was 1.853 ± 0.303 mm on the right side and 2.464 ± 0.311 mm on the left. It can be concluded that adeepened anatomical study of the foramen of Vesalius collaborates not only for anatomical knowledge of thisstructure, but also in clinical situations involving this foramen.

Incidence of the ossified pterygoalar ligamentin Brazilian human skulls and its clinical implications

The ossified pterygoalar ligament is formed between the lateral lamina of the pterygoid process and theinfratemporal surface of the sphenoid bone or its greater wing and was not connected to the sphenoid spine.The aim of this study was to evaluate the incidence of the ossified pterygoalar ligament in Brazilian humanskulls and analyzing its clinical importance. 183 Brazilian adult (between 30 to 60 years old) dry human skullswere evaluated. Was evaluated the incidence of skulls with complete or partial ossification of the pterygoalarligament, bilaterally and unilaterally and in the presence on the right and left sides. Were found 5 skulls had theossified pterygoalar ligament, resulting in an overall incidence of 2.73%. There was 1 skull in the presence ofthe incomplete ossification of the pterygoalar ligament, unilaterally and on the left side resulting in incidence of0.54%. There were 4 skulls in the presence of the complete ossification of the pterygoalar ligament, unilaterallyand on the right side resulting in incidence of 2.18%. The ossified pterygoalar ligament is a major cause of theentrapment of the lingual nerve or a branch of the mandibular nerve and may cause mandibular neuralgia. Theincidence of the ossified pterygoalar ligament and the pterygoalar foramen is low in the Brazilian population.However, these structures have clinical significance as this ligament establish relationships with the ovaleforamen and difficulty in accessing in this foramen in a therapeutic approach.

La determinación de PTH intraquirúrgica o posquirúrgica por quimioluminiscencia predice la hipocalcemia en el posoperatorio de la tiroidectomía en niños / Determination of PTH during or post surgery for quimioluminiscency can predict hypocalcemy in the post surgery children´s thyroidectomy

Objetivo: Evaluar la eficacia diagnóstica de la determinación de PTH en muestras de plasma tomadas durante la cirugía (intra) y posquirúrgica inmediata para predecir el riesgo de desarrollar hipocalcemia en el postoperatorio de la tiroidectomía total en pacientes pediátricos. Métodos: Se llevó a cabo un estudio de cohortes,prospectivo, longitudinal con 20 pacientes pediátricos en los que se practicó tiroidectomía total. Se determinaron los niveles de PTH preoperatorios, intraoperatorios y en el período posquirúrgico inmediato (basal, 5 y 60 minutos de la remoción de la glándula tiroides) utilizando un ensayo automatizado quimioluminiscente (IMMULITE, Siemens), límite de cuantificación 8 pg/mL, CV intra e interensayos < 5,4%. Para este estudio, la concentración de PTH de cada paciente no fue conocida por el equipo tratante hasta el final del mismo. Además se determinó la concentración en suero de Calcio total (Ca T) y/o Calcio iónico (Cai) regularmente durante las 48 hs posquirúrgicas y se controló la presencia de síntomas o signos de hipocalcemia. Se consideró hipocalcemia Ca T < 8 mg/dl y/o Cai < 0,8 nmol/L. Se realizó un análisis por curva ROC para determinar el nivel de PTH que fuera más eficaz en predecir la aparición de hipocalcemia según su sensibilidad (S), especificidad (E), eficiencia diagnóstica (ED) y Valor Predictivo Positivo (VPP). Resultados: Diez de los 20 pacientes (50%) desarrollaron hipocalcemia y 3 de ellos presentaron síntomas. La presentación de hipocalcemia sucedió: 40% en las primeras 6 hs y 40% a las 24 hs.vel de PTH en la muestra intraoperatoria < 14 pg/ml mostró S: 80%, E: 100%, ED: 90% (IC95%: 73-100) y VPP: 100% para predecir hipocalcemia posquirúrgica. En la muestra posquirúrgica inmediata, la concentración de PTH < 14 pg/ml presentó S: 80%, E: 90%, ED 82% (IC95% 63-100) y VPP 90% para predecir hipocalcemia posquirúrgica. Cuando la PTH intraquirúrgica o posquirúrgica es <14 pg/ml el riesgo relativo de presentar hipocalcemia postiroidectomía es de 9. Conclusiones: La medición de PTH intraquirúrgica y posquirúrgica es una herramienta eficiente para predecir hipocalcemia posquirúrgica por tiroidectomía total en la población pediátrica. Esta detección permite la inmediata decisión sobre el tratamiento suplementario con calcio en los pacientes de riesgo mejorando su evolución y evitando la presentación de tetania y otros síntomas de hipocalcemia. Además, permitiría disminuir los controles en los pacientes que evolucionarán con normocalcemia, reduciendo en ambos grupos de pacientes los costos de internación.

The Brachyura and Anomura fauna (Decapoda; Crustacea) in the Arvoredo Marine Biological Reserve on the southern brazilian coast

Eight species of Brachyura and two species of Anomura were registered for the first time on the Santa Catarina coast, in the waters around the Arvoredo Marine Biological Reserve. The animals were collected by scuba divers, between 3 and 22 meters depth, from September 2001 to February 2003. A total of 31 decapod species were collected, and most of the new occurrences had already been registered in the adjacent northern waters.

Oito espécies de Brachyura e duas espécies de Anomura foram registradas pela primeira vez na costa de Santa Catarina, em águas no entorno da Reserva Biológica Marinha do Arvoredo. Os animais foram coletados por meio de mergulho autônomo, entre 3 e 22 metros de profundidade, de setembro 2001 a fevereiro de 2003. Um total de 31 espécies de Decapoda foram coletadas e a maioria das novas ocorrências já haviam sido registradas em águas adjacentes ao norte da Reserva.

Comparación de crecimiento, desarrollo y estado de salud entre hijos de madres adolescentes y madres adultas / Comparison of growth, development and state of health between children of adolescent mothers and adult mothers

El presente es un estudio descriptivo que compara el crecimiento, desarrollo y estado de salud de hijos de madres adolescentes y adultas, y los factores relacionados a éste proceso. Utilizando variables sociodemográficas, nutricionales con valores antropométricos, desarrollo psicomotor e indicadores de salud tales como morbilidad, controles médicos, vacunas, lactancia materna. El diseño del estudio fue multivariado, de corte transversal, en el cual 55 niños primogénitos entre 6 y 12 meses de edad, hijos de madres adolescentes (10 a 19 años), fueron comparados con 55 niños de iguales condiciones, hijos de madres adultas (< de 20 años). La investigación se realizó para determinar si el grupo de hijos de madres adolescentes tiene mayor riesgo de presentar retraso del crecimiento, retraso de desarrollo y estado de salud inferior, con respecto del grupo de hijos de madres adultas...

Neurofibromatosis tipo-1

Paciente de 56 años de edad con cuadro compatible de Neurofibromatosis tipo-1; quien presenta lesiones generalizadas en piel (pápulas y nódulos), manchas café con leche de diferentes tamaños, lentiginosis axilar, 3 familiares directos establecidos por national Institute of Head. La biopsia de piel reporta neurofibroma compatible con la enfermedad de Von-Recklinghausen.

Thyroxin plasmal levels and sulfamethoxazol-Timetrhoprim total clearance in dogs

Os níveis plasmáticos de tiroxina (T4) foram determinados por radioimunoensaio em 9 cäes, antes da administraçäo, em dose única, via intramuscular ou intravenosa, de uma associaçäo (5:1) sulfametoxazol (SMT) - trimetropina (TMP), tendo a dose (30 mg/kg) sido calculada em relaçäo ao SMT. O clearance total (Clt) foi calculado para ambos os componentes da associaçäo após dosagem das concentraçöes sanguíneas, a intervalos regulares. Os níveis médios de T4 foram 1,01 mais ou menos 0,25 ug/dl, o Clt para o SMT e o TMP foram 1,38 mais ou menos 0,41 e 0,20 mais ou menos 0,04 l/kg/h respectivamente. Näo houve correlaçäo significativa entre os níveis de T4 e os valores de Clt para SMT ou para TMP

Estudos sobre os níveis sanguíneos de sulfametoxazol em caninos e ovinos: necessidade de adequaçäo do regime posológico / Sulphamethoxazol blood levels in dogs and sheep. Evidence for a differentiated dosage regimen

Os níveis sanguíenos de sulfametoxazol (SMT) foram determinados em caninos e ovinos, após administraçäo de produto comercial potencializado pela trimeoprina, em dose única de 30 mg/kg, por via intramuscular. Os níveis máximos alcançados foram: 6,52 mg/l em cäes, 4 h após a administraçäo, decaindo gradativamente até 24 h e 5,50 mg/l, em ovinos 2 h após a administraçäo, decaindo gradativamente até 12 h. A meia-vida biológica foi de 7,55 h para os caninos e 3,93 h, para os ovinos. O "clearance" total foi de 7,16 e 12,66 ml/min/kg, respectivamente no cäo e no carneiro. Cálculos adicionais mostraram que para se manter, nos ovinos, os mesmos níveis sanguíneos previstos para os caninos será necessário administrar dose 1,56 vezes maior ou diminuir o intervalo entre as administraçöes, nesta mesma proporçäo

Pharmacokinetic profile of tert-butylaminoethanethiol

A preliminary study of the pharmacokinetic parameters of t-Butylaminoethanethiol (TBAESH) was performed after administration of a single dose (35 mg/kg) either orally or intravenously. Plasma or blood samples were treated with dithiothreitol, perchloric acid and, after filtration, submitted to further purification with anionic resin. In the final step the drug was retained on a cationic resin column, eluted with NaCl lM and detected according to the method of Ellman (1958). The results suggested a pharmacokinetic behavior related to a one open compartment model with the following values for the total drug: area under the intravenous curve (AUC i.v.): 443(+ ou -) 24.0; AUC oral: 85.5(+ ou -) 14.5 ug min.ml(elevado a -1); elimination rate constant: 0.069(+ ou -) 0.0055 min(elevado a -1), biological half-life: 10.0(+ ou -) 0.80 min; distribution volume 1.15(+ ou -) 0.15 ml/g; biodisponibility: 0.19(+ ou -) 0.02. From a pharmacokinetic standpoint, TBAESH seems to have no advantage over the analogous disulfide compound

Pharmacokinetic aspects of Tert-Butylaminoethyl disulfide, an experimental drug against schistosomiasis in mice

Um estudo preliminar da farmacocinética do t-butilamino-etil-dissulfeto foi conduzido utilizando droga fria ou radioativa em duas diferentes doses (35 e 300 mg/Kg). Amostras de plasma ou sangue foram tratadas com ditiotreiol, ácido perclórico, e, após filtraçäo, submetidas a uma subseqüente purificaçäo em um "batch" de resina aniônica. Na etapa final, a droga foi retida em coluna de resina catiônica, eluída com NaCl 1 M e detectada pelo método de Ellman (1958). Alternativamente, a droga radioativa foi detectada por cintilaçäo líquida. Os resultados correspondentes a droga total administrada na menor dose sugeriram um comportamento farmacocinético relacionado ao modelo de um compartimento aberto, com os seguintes parâmetros: área sob a curva intravenosa (ASCI.V.): 671 ñ 14; ASCoral: 150 ñ 40 microng.min.ml-1; constante de eliminaçäo: 0,07 min-1; meia-vida biológica: 9,8 min; volume de distribuiçäo: 0,74 ml/g. Para a dose mais alta, os resultados indicaram aparentemente a ocorrência de um modelo mais complexo e näo adequadamente classificado. Analisados em conjunto os resultados sugerem a ocorrência de um comportamento farmacocinético dose-dependente. A droga é absorvida e eliminada rapidamente, sendo este último processo relacionado principalmente a metabolizaçäo. A droga parece mais tóxica quando administrada via I.V. porque por esta via ela näo sobre metabolismo de primeira passagem e, é, por outro lado rapidamente distribuída para os tecidos. O nível sanguíneo máximo tolerado pelos animais parece ser de 16 microng/ml

Xylazine antinociception in mice: evidence for mediation by postsynaptic adrenoceptors

The influence of 6-hydroxydopamine (6-OHDA) pretreatment on zylazine (XLZ)-induced antinociception was studied in mice using the writhing test (60 mg/Kg acetic acid, ip, as the algogenic compound administered 10 min after 0.5 0.75 mg/Kg XLZ, sc). 6-OHDA (100 mgKg-1 injection-1 administered ip on days 1, 3, 5, 7, 9 and 11 after bith) did not modify XLZ- induced antinociception, suggesting that effects is mediated by postsynaptic alpha-2 adrnoceptors

Edad de presentación de menarquia y su relación con el estado nutricional en la población rural de Tisaleo Tungurahua

La menarquía es el inicio de la menstruación causado por un incremento gradual en la secreción de hormona gonadotrófica, se conoce la incidencia de factores étnico-geográficos, nutricionales y hábitos de vida como determinantes de la aparición de la menarquía. En este estudio se analizó la edad de presentación de menarquía en un grupo de adolescentes de 10 a 18 años (n=87) en el que se obtuvo positividad en 22 personas de acuerdo a la edad en que fue encuestado. La media fue de 13 años con un rango entre los 11 a los 15 años. El mayor porcentaje se encontró a los 14 años (45.45 por ciento) y en orden de frecuencia 13, 12, 11 y 15. También se corroboran los datos de peso y talla encontrándose que los casos que presentan menarquía siempre se encuentran por encima de la media de estos datos obtenidos en la muestra total por edades (peso X=37.5g; talla x=137 cm).